Company & Sponsor Intelligence

Beth Israel Deaconess Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting2

Completed7

Countries1

Therapeutic footprint

epilepsyneuromuscularother_neurologypain_neuropathyparkinsons

Indexed studies

NCT01522235Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy
other_neurology · United StatesPHASE2, PHASE3

NCT07793461Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics
parkinsons · United StatesPHASE4

NCT00250484TMS Treatment for Pain in Chronic Pancreatitis
pain_neuropathy · United StatesNA

NCT02118805Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
parkinsons · United StatesCOMPLETED

NCT07145489Infrared Photobiomodulation in Humans With Epilepsy
epilepsy · United StatesNA

NCT00296413A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
epilepsy · United StatesCOMPLETED

NCT00029536Progesterone vs Placebo Therapy for Women With Epilepsy
epilepsy · United StatesPHASE3

NCT05883332A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
other_neurology · United StatesPHASE4

NCT05238038Electrical Impedance Tomography for the Assessment of Neurological Disease
neuromuscular · United StatesCOMPLETED

NCT01565395Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
parkinsons · United StatesPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →